|Bid||169.25 x 800|
|Ask||170.76 x 900|
|Day's Range||169.34 - 174.96|
|52 Week Range||112.60 - 187.67|
|Beta (5Y Monthly)||0.86|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 18, 2021 - May 24, 2021|
|Forward Dividend & Yield||1.68 (0.96%)|
|Ex-Dividend Date||Mar 01, 2021|
|1y Target Est||214.87|
Johnson & Johnson asked the Food and Drug Administration to authorize its single-shot coronavirus vaccine for emergency use in early February. That led JNJ stock to edge higher.
MCK earnings call for the period ending December 31, 2020.
Some might view McKesson (NYSE: MCK) as a kind of boring company. Healthcare supply chain management isn't the most exciting business in the world. But McKesson's stock performance has been anything but boring.